External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Dermatology Fall CDC 2025
Roche and Genentech at

Fall CDC 2025

October 23 - October 26
Las Vegas, USA / Virtual (Hybrid)
dermsquared.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:10 PM
Duration 60mins Las Vegas, USA
Impact of Baseline Biomarkers on Response to Omalizumab in Patients with Chronic Spontaneous Urticaria
Giselle Mosnaim
Dermatology | Chronic Idiopathic Urticaria

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Las Vegas, USA
Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
Giselle Mosnaim
Dermatology | Chronic Idiopathic Urticaria

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Las Vegas, USA
Matched-Adjusted Indirect Comparison Analysis Demonstrating Significantly Better Improvement in Patient-Reported Outcomes for Omalizumab vs Dupilumab at 12 Weeks in Patients with Chronic Spontaneous Urticaria
Giselle Mosnaim
Dermatology | Chronic Idiopathic Urticaria

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.